Featured

Dualis MedTech and ReliantHeart Partner on Fully Implantable TET System for the HeartAssist5® LVAD

ReliantHeart, Inc., an innovative supplier of advanced mechanical circulatory assist technologies, and Dualis MedTech GmbH, a provider of wireless energy and charging technology, have joined together to implement a wireless, Transcutaneous Energy Transfer system (TET) exclusively for the HeartAssist5® Ventricular Assist Device. Dualis has agreed to intergrate its wireless energy transfer technology MedBase® with the… Read more »

Kollmorgen and ReliantHeart Team Up to Produce Energy Efficient, Wireless LVAD

ReliantHeart, Inc., an innovative supplier of advanced mechanical circulatory assist technologies, and Kollmorgen, a leading provider of motion systems and components, announced a partnership to produce an energy efficient motor stator designed to cut the power consumption of the HeartAssist5® Left Ventricular Assist Device (LVAD) by 50%. Energy efficiency is the key to removing the… Read more »

LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5®

ReliantHeart, Inc., an innovative supplier of advanced mechanical circulatory assist technologies, and Transonic, a supplier of precision transit-time flow measurement solutions, are collaborating on a miniature flow board that will greatly improve the efficiency of the HeartAssist5® Left Ventricular Assist Device (LVAD). This will enable LVAD patients to experience greater mobility and peace of mind…. Read more »

First HeartAssist5® VAD Implant Performed in the U.S.

Chicago, Illinois. March 9, 2015. A patient at the University of Chicago Medicine was the first in the United States to be implanted with the HeartAssist5® Ventricular Assist Device (VAD) as part of an FDA clinical trial being conducted by Houston-based ReliantHeart, Inc. The HeartAssist5® VAD is a small mechanical pump implanted to support left… Read more »

ReliantHeart Commences FDA Trial on HeartAssist5® VAD

ReliantHeart Inc. has been granted approval from the U.S. Food and Drug Administration Center for Devices and Radiological Health (FDA/CDRH) to conduct an Investigational Device Exemption (IDE) Clinical Trial on the HeartAssist5® Ventricular Assist Device System for patients awaiting a heart transplant.

HeartAssistRemote™ Monitoring Powered by Numerex Receives 2014 M2M Telehealth Award

Network Enabled HeartAssistRemote™ Honored for Improving Healthcare Delivery ATLANTA – August 8, 2014.  Numerex (NASDAQ:NMRX), a leading provider of on-demand and interactive machine-to-machine (M2M) and Internet of Things (IoT) enterprise solutions, announced today that the HeartAssistRemote™ Monitoring System powered by Numerex has received a 2014 M2M Telehealth Award from M2M Evolution Magazine, the leading publication… Read more »

ReliantHeart’s HeartAssist5® achieves European CE Mark, which includes True Flow Remote Monitoring

Houston, Texas, May 15, 2014. The ReliantHeart HeartAssist5® Ventricular Assist Device (VAD) has attained CE Mark approval for design enhancements. The CE Mark which includes remote monitoring via VADLink.com provides remote and true flow measurement of the HeartAssist5®. The HeartAssist5® (HA5) measures True Flow. Flow is not estimated, it is accurately measured. Now True Flow is available over… Read more »

An Engineering Feat Gives Hearts Extra Life

Reliant’s system acts like your car’s dashboard. “If a patient’s pump has any sign of a challenge, like dehydration or low flow, the remote monitoring system signals the change to a data-collection center that notifies the transplant center as well as the individual,”